Skip to main content
Virulence logoLink to Virulence
editorial
. 2013 Jul 16;4(6):435–436. doi: 10.4161/viru.25747

Community-acquired pneumonia infections by Acinetobacter baumannii

How does alcohol impact the antimicrobial functions of macrophages?

Eliseo A Eugenin 1,*
PMCID: PMC5359724  PMID: 23863602

In this issue of Virulence, Asplund et al.,1 provides a proof of principle study indicating that physiological concentrations of alcohol impair macrophage antimicrobial functions against Acinetobacter baumannii (Ab). Thus, this communication delivers seminal evidence that alcohol and macrophages plays a key role the pathogenesis of Ab.

Ab is a wide spectrum of intrinsic and acquired multidrug-resistant gram-negative coccobacillus.2Ab has the ability to form biofilms on non-viable surfaces, surviving through high temperatures as well as extended periods of desiccation, making it a very resilient pathogen. Therefore, due to its high persistence, pathogenesis, and multidrug resistance, this pathogen has been associated with skin and soft tissue diseases, including necrotizing fasciitis, as well as lethal infections such as pneumonia, which can evolve to septic shock.3 In addition, in immunosuppressed individuals, Ab is considered a primary causative agent of community-acquired pneumonia (CAP-Ab)4-6 especially in association with alcohol abuse resulting in significant high mortality rate >50%.5,7,8 Data around the world indicates that Ab is a leading cause of severe and lethal CAP within various regions of the Asia Pacific such as Taiwan,9 Hong-Kong,7 Singapore,10 and Australia.4 In the case of biofilm formation, hospital acquired pneumonia caused by Ab (HAP-Ab) is typically acquired by patients in intensive care units via artificial ventilation in which mechanical tubing is commonly contaminated resulting in 35% mortality rate.7

In the context of drug resistance acquired by Ab, the more common resistances are to carbapenems, β-lactams, rifampicin, and emerging strains against once successful colistin have been isolated.7 Ab typically acquires resistance via antimicrobial inactivating enzymes such as lactamases, mutations within the bacterial genome that alters antimicrobial targets, and horizontal transfer with interactions with other microorganisms.7 Given the increasing difficulty in treating Ab infections, and the high mortality rates associated to this evolving pathogen, there is an urgent need to understand its biology and mechanisms of pathogenesis.

Despite its clinical importance, relatively little is known about the innate host defense mechanisms against respiratory Ab infection. Similar to the neutrophil, the macrophage is another important phagocyte that is generally involved in host defense against pathogen invasion. These professional phagocytic cells are one of the first innate immune cells in the respiratory tract to be activated after infection, and function to detect and eliminate invading pathogens while activating the adaptive immunity. Only recently, Qiu et al. showed that alveolar macrophages (AMs) are essential in the clearance and cellular immune response to Ab by microtubule- and microfilament-dependent phagocytosis.11 AMs upon stimulation produce elevated levels of pro-inflammatory cytokines upon stimulation, promoting the recruitment of neutrophils. Similarly, AMs produce high levels of nitric oxide (NO), an effector molecule that is important to combat Ab infection. However, it was unknown whether these mechanisms were present or altered in Ab infection in the presence or absence of alcohol abuse.

In the manuscript discussed here, for the first time, it has been proven that although macrophages are believed to play a relatively minor role in the overall host defense against Ab infection, they play an essential role in the initial stage of host defense against respiratory Ab infection, partially through an NO-dependent mechanism.1 In addition, an important effect of alcohol has been revealed in this study that explain, the majority of CAP-Ab infections and the impaired immune system observed in the individuals exposed to both Ab and alcohol consumption. Alcohol consumption is also correlated with impaired immune responses including AM dysfunction in phagocytosis, killing of bacteria, and cytokine secretion.4 However, there was no study available associating the direct effects of alcohol exposure on macrophage effector functions.

In this issue, Asplund et al. provide a proof-of-principle study suggesting that physiological alcohol concentrations impair macrophage antimicrobial functions against Ab using a J774.16 macrophage-like cell line. Alcohol-exposed macrophages shown decreased phagocytosis and killing of Ab. Interestingly, alcohol-mediated macrophage phagocytosis dysfunction may be associated with reduced expression of GTPase-RhoA, a key regulator of the actin polymerization signaling cascade and formation of the phagocytosis pocket, enabling the engulfment of the pathogen. Notably, this is the first study that suggests a specific protein expression cascade interruption in macrophages by alcohol leading to impairment of phagocytosis in the setting of a microbial infection. Furthermore, alcohol inhibited NO generation via inducible NO-synthase inactivation, which enhanced Ab survival within macrophages. Moreover, alcohol alters cytokine production, resulting in a dysregulated immune response, providing a plausible explanation for the occurrence of CAP-Ab-related complications, such as septic shock and impairment of adaptive immune cellular recruitment. This study opens a novel area of research and potential new therapeutic targets to reduce the devastating consequences of this opportunistic microbe that has been underestimated as a serious threat for human health.

Submitted

07/11/13

Accepted

07/13/13

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

References

  • 1.Asplund MB, Coelho C, Cordero RJB, Martinez LR. . Alcohol impairs J774.16 macrophage-like cell antimicrobial functions in Acinetobacter baumannii infection. Virulence 2013; 4:467 - 72; http://dx.doi.org/ 10.4161/viru.25641; PMID: 23863607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Maragakis LL, Perl TM. . Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254 - 63; http://dx.doi.org/ 10.1086/529198; PMID: 18444865 [DOI] [PubMed] [Google Scholar]
  • 3.Giamarellou H, Antoniadou A, Kanellakopoulou K. . Acinetobacter baumannii: a universal threat to public health?. Int J Antimicrob Agents 2008; 32:106 - 19; http://dx.doi.org/ 10.1016/j.ijantimicag.2008.02.013; PMID: 18571905 [DOI] [PubMed] [Google Scholar]
  • 4.Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. . Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002; 40:685 - 6; http://dx.doi.org/ 10.1128/JCM.40.2.685-686.2002; PMID: 11825997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Peng C, Zong Z, Fan H. . Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China. Clin Microbiol Infect 2012; 18:E491 - 3; PMID: 23057470 [DOI] [PubMed] [Google Scholar]
  • 6.Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. . Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007; 26:857 - 68; http://dx.doi.org/ 10.1007/s10096-007-0365-6; PMID: 17701432 [DOI] [PubMed] [Google Scholar]
  • 7.Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. . Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006; 129:102 - 9; http://dx.doi.org/ 10.1378/chest.129.1.102; PMID: 16424419 [DOI] [PubMed] [Google Scholar]
  • 8.Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. . Severe community-acquired pneumonia due to Acinetobacter baumannii.. Chest 2001; 120:1072 - 7; http://dx.doi.org/ 10.1378/chest.120.4.1072; PMID: 11591541 [DOI] [PubMed] [Google Scholar]
  • 9.Wang JT, McDonald LC, Chang SC, Ho M. . Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan. J Clin Microbiol 2002; 40:1526 - 9; http://dx.doi.org/ 10.1128/JCM.40.4.1526-1529.2002; PMID: 11923388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ong CW, Lye DC, Khoo KL, Chua GS, Yeoh SF, Leo YS, et al. . Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 2009; 14:1200 - 5; http://dx.doi.org/ 10.1111/j.1440-1843.2009.01630.x; PMID: 19909464 [DOI] [PubMed] [Google Scholar]
  • 11.Qiu H, KuoLee R, Harris G, Van Rooijen N, Patel GB, Chen W. . Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One 2012; 7:e40019; http://dx.doi.org/ 10.1371/journal.pone.0040019; PMID: 22768201 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virulence are provided here courtesy of Taylor & Francis

RESOURCES